BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34607976)

  • 1. Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study.
    Ng TKS; Coughlan C; Heyn PC; Tagawa A; Carollo JJ; Kua EH; Mahendran R
    Aging (Albany NY); 2021 Oct; 13(19):22666-22689. PubMed ID: 34607976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the diagnostic value of peripheral BDNF levels for Alzheimer's disease and mild cognitive impairment: results of a meta-analysis.
    Xie B; Zhou H; Liu W; Yu W; Liu Z; Jiang L; Zhang R; Cui D; Shi Z; Xu S
    Int J Neurosci; 2020 Mar; 130(3):218-230. PubMed ID: 31518516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
    Fang Y; Du N; Xing L; Duo Y; Zheng L
    Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer's Disease (AD): A Systematic Review and Meta-Analysis.
    Ng TKS; Ho CSH; Tam WWS; Kua EH; Ho RC
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects.
    Forlenza OV; Miranda AS; Guimar I; Talib LL; Diniz BS; Gattaz WF; Teixeira AL
    J Alzheimers Dis; 2015; 46(2):423-9. PubMed ID: 25737042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commonalities in biomarkers and phenotypes between mild cognitive impairment and cerebral palsy: a pilot exploratory study.
    Ng TKS; Tagawa A; Ho RC; Larbi A; Kua EH; Mahendran R; Carollo JJ; Heyn PC
    Aging (Albany NY); 2021 Jan; 13(2):1773-1816. PubMed ID: 33497355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
    Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
    J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
    Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
    Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.
    Xie B; Xu Y; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 56(1):391-401. PubMed ID: 27935556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277).
    Qin XY; Cao C; Cawley NX; Liu TT; Yuan J; Loh YP; Cheng Y
    Mol Psychiatry; 2017 Feb; 22(2):312-320. PubMed ID: 27113997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Serum Levels of Brain-Derived Neurotrophic Factor Are Related to Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.
    Sun ZC; Yu J; Liu YL; Hong ZZ; Ling L; Li GQ; Zhuo YF; Wang WR; Zhang Y
    Ann Nutr Metab; 2018; 73(4):271-281. PubMed ID: 30308512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
    Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
    J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
    Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Serum miR-206 Level Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Follow-up Study.
    Xie B; Liu Z; Jiang L; Liu W; Song M; Zhang Q; Zhang R; Cui D; Wang X; Xu S
    J Alzheimers Dis; 2017; 55(2):509-520. PubMed ID: 27662297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China.
    Zheng T; Liu H; Qin L; Chen B; Zhang X; Hu X; Xiao L; Qin S
    Metabolism; 2018 Oct; 87():105-112. PubMed ID: 29572131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and BDNF serum levels.
    Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
    Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
    Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
    Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tai Chi Improves Cognition and Plasma BDNF in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial.
    Sungkarat S; Boripuntakul S; Kumfu S; Lord SR; Chattipakorn N
    Neurorehabil Neural Repair; 2018 Feb; 32(2):142-149. PubMed ID: 29353543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.
    Nagata T; Kobayashi N; Shinagawa S; Yamada H; Kondo K; Nakayama K
    J Neural Transm (Vienna); 2014 Apr; 121(4):433-41. PubMed ID: 24253237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.